.
MergerLinks Header Logo

New Deal


Announced

Completed

Paine Schwartz Partners completed the acquisition of a stake in Hendrix Genetics from NPM Capital.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For50%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Biotechnology

Acquisition

Netherlands

Minority

Cross Border

Friendly

Private Equity

animal genetics

Single Bidder

Private

Completed

Synopsis

Edit

Paine Schwartz Partners, a private equity firm specializing in sustainable food chain investing, completed the acquisition of a stake in Hendrix Genetics, a multi-species animal genetics and technology company, from NPM Capital, a private equity firm. Financial terms were not disclosed. "This strategic investment in Hendrix Genetics is directly aligned with our long-term thesis of identifying companies that sustainably increase productivity in the production of agriculture commodities, which is required to feed an ever-growing global population. We are pleased to be joined in this investment by co-investors who also recognize the significant value creation opportunity ahead for Hendrix Genetics and its data and technology-enabled breeding programs. We look forward to working in partnership with Thijs and Antoon to support Jolanda and the entire Hendrix Genetics team to drive the Company's next phase of growth," Kevin Schwartz, Paine Schwartz CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US